Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06606730 |
| Title | Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer (OPT-PEMBRO) |
| Acronym | OPT-PEMBRO |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | UNICANCER |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA | BEL |